EPIX
EPIX
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $4.996M ▼ | $-4.003M ▲ | 0% | $-0.09 ▲ | $-4.98M ▲ |
| Q2-2025 | $0 | $7.358M ▼ | $-6.375M ▲ | 0% | $-0.14 ▲ | $-6.351M ▲ |
| Q1-2025 | $0 ▼ | $9.661M ▲ | $-8.532M ▼ | 0% ▲ | $-0.19 ▼ | $-8.509M ▼ |
| Q4-2024 | $135.754K ▲ | $7.695M ▼ | $-6.355M ▲ | -4.681K% ▼ | $-0.14 ▲ | $-6.332M ▲ |
| Q3-2024 | $0 | $8.638M | $-7.234M | 0% | $-0.16 | $-7.211M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $109.62M ▼ | $110.502M ▼ | $1.6M ▼ | $108.902M ▼ |
| Q2-2025 | $113.872M ▼ | $115.415M ▼ | $1.869M ▼ | $113.547M ▼ |
| Q1-2025 | $120.553M ▼ | $122.634M ▼ | $3.867M ▲ | $118.767M ▼ |
| Q4-2024 | $126.76M ▼ | $128.112M ▼ | $3.506M ▼ | $124.606M ▼ |
| Q3-2024 | $130.694M | $132.666M | $3.805M | $128.862M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.003M ▲ | $-4.2M ▲ | $3.844M ▲ | $0 | $-355.758K ▲ | $-4.2M ▲ |
| Q2-2025 | $-6.375M ▲ | $-6.849M ▼ | $-153.89K ▲ | $0 | $-7.003M ▲ | $-6.849M ▼ |
| Q1-2025 | $-8.532M ▼ | $-6.47M ▼ | $-3.929M ▼ | $0 ▼ | $-10.399M ▼ | $-6.47M ▼ |
| Q4-2024 | $-6.355M ▲ | $-3.366M ▲ | $21.024M ▲ | $59.671K ▲ | $17.724M ▲ | $-3.366M ▲ |
| Q3-2024 | $-7.234M | $-5.745M | $23.487K | $25.577K | $-5.698M | $-5.745M |
About ESSA Pharma Inc.
https://www.essapharma.comESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $4.996M ▼ | $-4.003M ▲ | 0% | $-0.09 ▲ | $-4.98M ▲ |
| Q2-2025 | $0 | $7.358M ▼ | $-6.375M ▲ | 0% | $-0.14 ▲ | $-6.351M ▲ |
| Q1-2025 | $0 ▼ | $9.661M ▲ | $-8.532M ▼ | 0% ▲ | $-0.19 ▼ | $-8.509M ▼ |
| Q4-2024 | $135.754K ▲ | $7.695M ▼ | $-6.355M ▲ | -4.681K% ▼ | $-0.14 ▲ | $-6.332M ▲ |
| Q3-2024 | $0 | $8.638M | $-7.234M | 0% | $-0.16 | $-7.211M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $109.62M ▼ | $110.502M ▼ | $1.6M ▼ | $108.902M ▼ |
| Q2-2025 | $113.872M ▼ | $115.415M ▼ | $1.869M ▼ | $113.547M ▼ |
| Q1-2025 | $120.553M ▼ | $122.634M ▼ | $3.867M ▲ | $118.767M ▼ |
| Q4-2024 | $126.76M ▼ | $128.112M ▼ | $3.506M ▼ | $124.606M ▼ |
| Q3-2024 | $130.694M | $132.666M | $3.805M | $128.862M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.003M ▲ | $-4.2M ▲ | $3.844M ▲ | $0 | $-355.758K ▲ | $-4.2M ▲ |
| Q2-2025 | $-6.375M ▲ | $-6.849M ▼ | $-153.89K ▲ | $0 | $-7.003M ▲ | $-6.849M ▼ |
| Q1-2025 | $-8.532M ▼ | $-6.47M ▼ | $-3.929M ▼ | $0 ▼ | $-10.399M ▼ | $-6.47M ▼ |
| Q4-2024 | $-6.355M ▲ | $-3.366M ▲ | $21.024M ▲ | $59.671K ▲ | $17.724M ▲ | $-3.366M ▲ |
| Q3-2024 | $-7.234M | $-5.745M | $23.487K | $25.577K | $-5.698M | $-5.745M |
CEO
David Ross Parkinson
Compensation Summary
(Year 2024)
CEO
David Ross Parkinson
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2018-04-25 | Reverse | 1:20 |
Price Target
Institutional Ownership
BVF INC/IL
11.668M Shares
$2.348M
SOLEUS CAPITAL MANAGEMENT, L.P.
4.362M Shares
$877.64K
MORGAN STANLEY
1.904M Shares
$383.097K
PFIZER INC
1.675M Shares
$337.01K
CLARUS VENTURES, LLC
1.669M Shares
$335.714K
BANK OF AMERICA CORP /DE/
591.834K Shares
$119.077K
LMR PARTNERS LLP
540.984K Shares
$108.846K
SHAY CAPITAL LLC
536.533K Shares
$107.95K
TWO SIGMA INVESTMENTS, LP
336.164K Shares
$67.636K
BURRAGE CAPITAL MANAGEMENT LLC
237.442K Shares
$47.773K
TWO SIGMA ADVISERS, LP
214.8K Shares
$43.218K
CITADEL ADVISORS LLC
144.449K Shares
$29.063K
CSS LLC/IL
103.488K Shares
$20.822K
VIRTU FINANCIAL LLC
77.036K Shares
$15.5K
YAKIRA CAPITAL MANAGEMENT, INC.
72.123K Shares
$14.511K
MAGNUS FINANCIAL GROUP LLC
55.206K Shares
$11.107K
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)
51.973K Shares
$10.457K
XTX TOPCO LTD
45.524K Shares
$9.159K
LEPERCQ MULTI-ASSET FUND
30.2K Shares
$6.076K
BEAUMONT CAPITAL MANAGEMENT, LLC
28.225K Shares
$5.679K
Summary
Only Showing The Top 20